Composition and kit for methylation noninvasive early detection of gynecological tumours
A technology for early detection of gynecological tumors, applied in recombinant DNA technology, biochemical equipment and methods, and microbial determination/examination. And other issues
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0085] Detection kit for detection of methylation of gynecological malignancy-related genes PTGER4, HAND2, PAX1, HOXA9, FOXD3, OPCML, HS3ST2 and JAM3.
[0086] The specific nucleotide sequences of the primers and probes used are shown in the table below:
[0087]
[0088]
[0089] Note: F represents the forward detection primer, R represents the reverse detection primer, and FP represents the detection probe. In this table, the probe sequences shown have been fluorescently labeled and quenched.
[0090] The kit components are as follows:
[0091]
[0092]
[0093] Select 70 cases of ovarian cancer samples with known clear pathological information: 30 cases were identified as high-grade serous carcinoma, 20 cases of low-grade serous carcinoma, 10 cases of clear cell carcinoma, 10 cases of mucinous carcinoma; 40 cases were identified as benign ovarian samples .
[0094] Select 60 cases of endometrial cancer samples with known clear pathological information: 15 cas...
Embodiment 2
[0126] The specific nucleotide sequences of the primers and probes used are shown in the table below:
[0127]
[0128]
[0129] Note: F represents the forward detection primer, R represents the reverse detection primer, and FP represents the detection probe. In this table, the probe sequences shown have been fluorescently labeled and quenched.
[0130] Other components in the kit are the same as in Example 1.
[0131] Compared with clinicopathological results, the combined ROC curve area obtained by using this methylation detection kit is 0.894 (see Figure 4 ), the overall specificity was 97.5%, the detection sensitivity of ovarian cancer was 90%, the detection sensitivity of endometrial cancer was 86.7%, and the detection sensitivity of cervical cancer was 86%. Among them, the detection rates of high-grade serous ovarian cancer, low-grade serous ovarian cancer, clear cell ovarian cancer and mucinous ovarian cancer were 90%, 90%, 90% and 90% respectively; The detect...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com